Haldol

Haldol antipsychotic medication is often used for the treatment of schizophrenia symptoms. The risk of suffering Tardive Dyskinesia with the use of antipsychotic medications like Haldol is a risk that has been found to occur at a greater frequency with elderly patients. In 2000, the FDA’s Medwatch had a new subsection added to Haldol labeling. The Haldol precautions included a ‘Geriatric Use’ section to warn that there were insufficient numbers of subjects in the ages of 65 and older represented in Haldol clinical studies to determine if these Haldol patients responded differently from younger Haldol patients.

This Haldol labeling change was incredibly significant because while regulators are still unsure of why there is a link between Tardive Dyskinesia and antipsychotics it has been observed that elderly patients are more at risk for suffering it. An irreversible condition in some instances, Tardive Dyskinesia occurrence becomes greater the longer antipsychotics like Haldol are used. Since Haldol is normally prescribed for the management of long-term care of antipsychotic therapy, it is essential that all patients are aware of the Haldol side effects and that doctors continue to monitor for early warning signs of adverse effects.
For more information on Haldol contact us to confer with a Haldol lawyer.